Publication Name	World Journal of Gastroenterology
Manuscript ID	46670
Country	China

Received	2019-03-06 07:06
Peer-Review Started	2019-03-06 08:09
To Make the First Decision	2019-04-17 00:49
Return for Revision	2019-04-17 02:37
Revised	2019-04-28 12:14
Second Decision	2019-05-17 08:55
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2019-05-18 12:47
Articles in Press	2019-05-18 12:47
Publication Fee Transferred
Edit the Manuscript by Language Editor	2019-05-29 20:03
Typeset the Manuscript	2019-07-04 07:13
Publish the Manuscript Online	2019-07-06 06:23

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
Manuscript Source	Invited Manuscript
All Author List	Yu Jiang, Qiu-Ju Han and Jian Zhang
Funding Agency and Grant Number
Corresponding Author	Jian Zhang, PhD, Professor, Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, 44 Wenhua West Road, Jinan 250012, Shandong Province, China. zhangj65@sdu.edu.cn
Key Words	Hepatocellular carcinoma; Mechanisms; Immunotherapy
Core Tip	Among all primary liver cancers, hepatocellular carcinoma (HCC) is the most common and accounts for 90% of cases. Mechanisms related to HCC progression and treatment strategies have been extensively reported. In this paper, we reviewed the molecular mechanisms involved in the progression of HCC and the latest advancements in immunotherapy by combining the research progress and results from our laboratory in recent years.
Publish Date	2019-07-06 06:23
Citation	Jiang Y, Han QJ, Zhang J. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy. World J Gastroenterol 2019; 25(25): 3151-3167
URL	https://www.wjgnet.com/1007-9327/full/v25/i25/3151.htm
DOI	https://dx.doi.org/10.3748/wjg.v25.i25.3151

Full Article (PDF)	WJG-25-3151.pdf
Full Article (Word)	WJG-25-3151.docx
Manuscript File	FP6860_de26_CE1MS-confirmed version.docx
Answering Reviewers	46670-Answering reviewers.pdf
Audio Core Tip	46670-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	46670-Conflict-of-interest statement.pdf
Copyright License Agreement	46670-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	46670-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	46670-Language certificate.pdf
Peer-review Report	46670-Peer-review(s).pdf
Scientific Misconduct Check	46670-Google-MA RY-1.png
Scientific Misconduct Check	46670-Google-MA RY-2.png
Scientific Misconduct Check	46670-Scientific misconduct check.pdf
Scientific Editor Work List	46670-Scientific editor work list.pdf